Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

被引:9
|
作者
Xu, Hongen [1 ]
You, Guangxian [2 ]
Zhang, Minjun [1 ,3 ]
Song, Tao [1 ]
Zhang, Haibo [1 ]
Yang, Jia [1 ]
Jia, Yongshi [1 ]
Tang, Jianming [1 ]
Liang, Xiaodong [1 ]
机构
[1] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Dept Radiat Oncol, Canc Ctr,Peoples Hosp, 158 Shangtang Rd, Hangzhou 310014, Zhejiang, Peoples R China
[2] Taizhou Canc Hosp, Dept Radiat Oncol, Taizhou 317502, Peoples R China
[3] Bengbu Med Coll, Grad Dept, 2600 Donghai Ave, Bengbu 233000, Peoples R China
关键词
Rectal cancer; Lymphocyte counts; Disease-free survival; Chemoradiotherapy; ACUTE HEMATOLOGIC TOXICITY; DOSIMETRIC PARAMETERS; CERVICAL-CANCER; LYMPHOPENIA; CHEMORADIATION; CHEMOTHERAPY; PREDICTORS; MARKER; TUMOR;
D O I
10.1186/s12957-019-1747-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Colorectal cancer is the fourth most common cancer globally and neoadjuvant concurrent chemoradiotherapy (nCRT) and surgery are the standard treatments for locally advanced colorectal carcinoma. This study investigated the association between dynamic changes in absolute lymphocyte counts (ALCs) and disease-free survival (DFS) in rectal cancer patients receiving nCRT and identified factors associated with these changes. Methods We retrospectively examined 34 patients with locally advanced rectal cancer who received nCRT followed by surgery and adjuvant chemotherapy. The association between ALCs and DFS and that between ALCs and downstaging were analyzed and potential clinical- and treatment-related factors related to dynamic changes in ALCs were subsequently evaluated. The patient eligibility criteria were as follows: pathologically confirmed rectal adenocarcinoma, clinical stages II-III, >= 18 years of age, and so on. Pre-RTL was defined as ALCs obtained before the initiation of nCRT and pre-SL was defined as ALCs obtained before surgery. We measured pre-SL to pre-RTL ratio (pre-SLR), DFS, and ALCs. Results The median ALC declined significantly during nCRT. A lower pre-SLR was associated with poorer DFS with statistical significance in Kaplan-Meier (p = 0.007), univariate regression (hazard ratio [HR] = 6.287, 95% confidence interval [CI] 1.374-28.781, p = 0.018), and multivariable regression (HR = 7.347, 95% CI 1.595-33.850, p = 0.011) analyses. Neither patient characteristics nor treatment-related factors were related to downstaging. The pelvic bone marrow (PBM) volume receiving at least 30 Gy (V30) was significantly associated with pre-SLR in the univariate (HR = 5.760, 95% CI 1.317-25.187, p = 0.020) and multivariable (HR = 5.760, 95% CI 1.317-25.187, p = 0.020) regression analyses. Limitations Our study had several limitations. The sample size was small and the study was performed in a selected population, which may limit the generalization of the findings. Conclusions Radiotherapy had a profound impact on the change in ALCs. A lower pre-SLR was significantly associated with poorer DFS in rectal cancer patients receiving nCRT. The V30 of PBM was a predictor of pre-SLR.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery
    Kai-Lin Yang
    Shung-Haur Yang
    Wen-Yih Liang
    Ying-Ju Kuo
    Jen-Kou Lin
    Tzu-Chen Lin
    Wei-Shone Chen
    Jeng-Kae Jiang
    Huann-Sheng Wang
    Shih-Ching Chang
    Lee-Shing Chu
    Ling-Wei Wang
    Radiation Oncology, 8
  • [42] Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation
    Yu, Brian
    Ma, Sung Jun
    Khan, Michael
    Gill, Jasmin
    Iovoli, Austin
    Fekrmandi, Fatemeh
    Farrugia, Mark K.
    Wooten, Kimberly
    Gupta, Vishal
    McSpadden, Ryan
    Kuriakose, Moni A.
    Markiewicz, Michael R.
    Al-Afif, Ayham
    Hicks, Wesley L.
    Seshadri, Mukund
    Ray, Andrew D.
    Repasky, Elizabeth A.
    Singh, Anurag K.
    BMC CANCER, 2023, 23 (01)
  • [43] Pre-operative neutrophil-lymphocyte ratio and its association with survival after curative resection in breast cancer patients
    Hakeem, A.
    West, M.
    Stefanidis, E.
    Hardy, R.
    Martin, L.
    BRITISH JOURNAL OF SURGERY, 2010, 97 : 98 - 98
  • [44] Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation
    Brian Yu
    Sung Jun Ma
    Michael Khan
    Jasmin Gill
    Austin Iovoli
    Fatemeh Fekrmandi
    Mark K. Farrugia
    Kimberly Wooten
    Vishal Gupta
    Ryan McSpadden
    Moni A. Kuriakose
    Michael R. Markiewicz
    Ayham Al-Afif
    Wesley L. Hicks
    Mukund Seshadri
    Andrew D. Ray
    Elizabeth A. Repasky
    Anurag K. Singh
    BMC Cancer, 23
  • [45] Pre-surgical neutrophil-to-lymphocyte ratio (NLR) is a prognostic indicator of recurrence free and overall survival in breast cancer patients undergoing primary surgery
    Connor, Derbrenn O.
    Griffin, Mark L.
    O'Sullivan, Jenna S.
    Millar, Sean
    O'Keeffe, Jo
    Bird, Brian R.
    Deady, Sandra
    Murphy, Conleth G.
    CANCER RESEARCH, 2015, 75
  • [46] MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and Its Association with Disease-Free and Overall Survival
    Hannah M. Thompson
    David D. B. Bates
    Jennifer Golia Pernicka
    Sun Jin Park
    Mahra Nourbakhsh
    James L. Fuqua
    Megan Fiasconaro
    Jessica A. Lavery
    Iris H. Wei
    Emmanouil P. Pappou
    J. Joshua Smith
    Garrett M. Nash
    Martin R. Weiser
    Philip B. Paty
    Julio Garcia-Aguilar
    Maria Widmar
    Annals of Surgical Oncology, 2023, 30 : 3957 - 3965
  • [47] MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and Its Association with Disease-Free and Overall Survival
    Thompson, Hannah M. M.
    Bates, David D. B.
    Pernicka, Jennifer Golia
    Park, Sun Jin
    Nourbakhsh, Mahra
    Fuqua, James L. L.
    Fiasconaro, Megan
    Lavery, Jessica A. A.
    Wei, Iris H. H.
    Pappou, Emmanouil P. P.
    Smith, J. Joshua
    Nash, Garrett M. M.
    Weiser, Martin R. R.
    Paty, Philip B. B.
    Garcia-Aguilar, Julio
    Widmar, Maria
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (07) : 3957 - 3965
  • [48] Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer 5-year disease-free and overall survival data
    Vriens, B.
    Aarts, M.
    Van Gastel, S.
    Van den Berkmortel, F.
    Smilde, T.
    Van Warmerdam, L.
    De Boer, M.
    Van Spronsen, D. J.
    Peer, P.
    Tjan-Heijnen, V.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S100 - S100
  • [49] THE ELEVATED PRE-OPERATIVE PLASMA FIBRINOGEN LEVEL IS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR FOR DISEASE-FREE SURVIVAL IN OVARIAN CANCER PATIENTS
    Ebina, Y.
    Murata, Y.
    Nagamata, S.
    Suzuki, K.
    Wakahashi, S.
    Miyahara, Y.
    Yamada, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 668 - 668
  • [50] Serum apolipoprotein B to apolipoprotein A-I ratio is an independent predictor of liver metastasis from locally advanced rectal cancer in patients receiving neoadjuvant chemoradiotherapy plus surgery
    Chen Chen
    Wei Yi
    Zhi-fan Zeng
    Qiao-xuan Wang
    Wu Jiang
    Yuan-hong Gao
    Hui Chang
    BMC Cancer, 22